Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis

NCT03684759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-09-26

No results posted yet for this study

Summary

The aim of this pilot study is to demonstrate the feasibility of viral biomolecular diagnosis in sputum compared to nasopharyngeal swab in cystic fibrosis acute respiratory infection.

Conditions

Sponsors & Collaborators

  • University Hospital, Brest

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-24
Primary Completion
2017-02-06
Completion
2017-02-06

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03684759 on ClinicalTrials.gov